D-0611-2024 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0611-2024 was initiated by RemedyRepack Inc. on Jun 26, 2024 and is designated Class II. Reason for recall: CGMP Deviations: Out of specification for dissolution The recall status is terminated (terminated Jan 31, 2025). Affected quantity: 142 blister cards, 30 per blister card.

Recall details

Product Type
Drugs
Report Date
Jul 24, 2024
Initiation Date
Jun 26, 2024
Termination Date
Jan 31, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
142 blister cards, 30 per blister card

Product description

Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only, MFG: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1203-03

Reason for recall

CGMP Deviations: Out of specification for dissolution

Distribution pattern

USA Nationwide

Code information

Lot #: J0758674-021824, Exp 03/31/2025; J0751898-011424, Exp 01/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0611-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0611-2024. Report a data issue: hello@regdatalab.com.